Qiming Venture Partners — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Apollomics is a biotechnology company focused on discovering and developing oncology therapies designed to combine with other treatments, using approaches that engage the immune system and target specific molecular pathways to inhibit cancer.
BiotechHealthtechFoster City, US
Peter Lin(Executive Officer)
BoardHung-Wen (Howard) Chen(Executive Officer, Director)Hung-Hsien Yen(Director)Yi-Kuei (Alex) Chen(Executive Officer, Director)Hong-Jung (Moses) Chen(Director)Hsien-Shu (Jerry) Tsai(Director)
Co-investorsMaxpro VenturesPan-Lin Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.